Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hepatitis
  Free Subscription

Articles published in
J Virol
    October 2026
  1. TERASAKI K, Makino S
    Rift Valley fever virus virulence factor NSs targets ATF4- and XBP1-driven unfolded protein response.
    J Virol. 2026;100:e0123326.
    >> Share

  2. WU S, Huang Y, Xu J, Li J, et al
    UFMylation of SHBs increases protein stability by antagonizing ubiquitination and promotes virion production.
    J Virol. 2026;100:e0103426.
    >> Share

  3. FLOR R, Stocker T, Petraccione K, Akhrymuk M, et al
    BTX-A51 treatment modulates host innate immune responses via NF-kappaB and beta-catenin signaling during Rift Valley fever virus infection in vitro.
    J Virol. 2026;100:e0104226.
    >> Share

  4. ITO M, Li X, Liu J, Matsuda M, et al
    Temporal dissection of hepatitis C virus and orthoflavivirus infections by continuous luminescence monitoring.
    J Virol. 2026 Oct 12:e0126626. doi: 10.1128/jvi.01266.
    >> Share

    September 2026
  5. STEIGMANN JC, Zhou X, Suttenberg LN, Salman I, et al
    Erratum for Steigmann et al., "Effects of immunoproteasome inhibition on acute respiratory infection with murine hepatitis virus strain 1".
    J Virol. 2026 Sep 15:e0137026. doi: 10.1128/jvi.01370.
    >> Share

  6. GOMEZ-ESCOBAR E, Siddique A, Khedr O, Bedard N, et al
    Virus-specific T cells and neutralizing antibodies are independent correlates of long-term protective immunity against hepatitis C virus.
    J Virol. 2026 Sep 10:e0084926. doi: 10.1128/jvi.00849.
    >> Share

  7. LEE J, Chuang Y-C, Lee JA, Ou J-HJ, et al
    Protein kinase D1 regulates innate immune signaling pathways to promote hepatitis C virus replication.
    J Virol. 2026 Sep 9:e0069326. doi: 10.1128/jvi.00693.
    >> Share

  8. CHAZOVA O, Zaiets I, Gudima SO
    Natural immune escape mutations in the envelope proteins of hepatitis B virus (HBV) regulate the assembly and infectivity of human hepatitis delta virus (HDV).
    J Virol. 2026 Sep 1:e0106326. doi: 10.1128/jvi.01063.
    >> Share

    July 2026
  9. CHAZOVA O, Zaiets I, Gudima SO
    Drug resistance mutations of hepatitis B virus (HBV) influence the yield of the virions of the human hepatitis delta virus (HDV) and their infectivity.
    J Virol. 2026 Jul 13:e0061026. doi: 10.1128/jvi.00610.
    >> Share

    June 2026
  10. STERLING CE, Rush RE, McGaughey JJ, Snow BA, et al
    Oropouche virus causes acute hepatitis in mice controlled by type I interferons.
    J Virol. 2026 Jun 30:e0061126. doi: 10.1128/jvi.00611.
    >> Share

  11. JIAO M, Konno A, Wang X, Liu J, et al
    Assembly of lipid droplet-associated ring structures in hepatitis C virus-infected cells via liquid-liquid phase separation (LLPS) and non-LLPS mechanisms.
    J Virol. 2026 Jun 26:e0078026. doi: 10.1128/jvi.00780.
    >> Share

  12. ZHANG H, Liu Y, Xu T, Luan J, et al
    Palmitoylation of CLDN12 regulated by ZDHHC7 and APT1/2 promotes hepatitis C virus entry.
    J Virol. 2026 Jun 18:e0063826. doi: 10.1128/jvi.00638.
    >> Share

  13. ELGENDY E, Tripathi SK, Luo G
    Promotion of hepatitis B virus infection by extracellular apolipoprotein E.
    J Virol. 2026 Jun 10:e0020926. doi: 10.1128/jvi.00209.
    >> Share

    April 2026
  14. WANG M, Chen Q, Zheng Y, Yin J, et al
    RANBP3 and RAN orchestrate CRM1-mediated nuclear export of hepatitis B virus RNAs.
    J Virol. 2026 Apr 30:e0026726. doi: 10.1128/jvi.00267.
    >> Share

  15. KENNEDY MJ, Wolfisberg R, Lundsgaard EA, Thorselius CE, et al
    Development of a Norway rat hepacivirus reporter for high-throughput quantification of neutralizing antibodies.
    J Virol. 2026;100:e0194325.
    >> Share

  16. WU M-J, Healy P, Chang C-W, Welsch C, et al
    Hepatitis C virus p7 regulates Core protein processing via signal peptide peptidase to promote virion assembly.
    J Virol. 2026 Apr 17:e0028826. doi: 10.1128/jvi.00288.
    >> Share

    March 2026
  17. XIA Y, Chen S, He Q, Cong C, et al
    HEV replication is promoted by blocking the NF-kappaB signaling pathway through inhibiting FLNa expression.
    J Virol. 2026;100:e0197725.
    >> Share

    February 2026
  18. CONNORS KA, Frey ZD, Demers MJ, Midgett M, et al
    Rift Valley fever virus activates multiple cell death pathways in neurons.
    J Virol. 2026;100:e0174225.
    >> Share

    December 2025
  19. WANG Y, Li Y, Xu R, Yuan T, et al
    GRP75 blocks hepatitis E virus infection by targeting HEV-ORF2 for degradation through chaperone-mediated autophagy and promoting IRF3 activation.
    J Virol. 2025 Dec 17:e0134425. doi: 10.1128/jvi.01344.
    >> Share

  20. TILLER K, Williams ST, Wang B, Tian D, et al
    Reactive oxygen species promotion drives auranofin's antiviral activity against hepatitis E virus.
    J Virol. 2025 Dec 9:e0191725. doi: 10.1128/jvi.01917.
    >> Share

    November 2025
  21. ZHANG B-H, Zhou Y, Horrigan S, Zoulim F, et al
    Replication-driven HBV cccDNA loss in chimeric mice with humanized livers.
    J Virol. 2025;99:e0129525.
    >> Share

    October 2025
  22. ZAIETS I, Chazova O, Gunewardena S, Gudima SO, et al
    HCC-derived SNU cell lines as model systems to study HBV life cycle.
    J Virol. 2025;99:e0114425.
    >> Share

  23. MISUMI I, Li Y, Shirasaki T, Yang L, et al
    Natural killer cells and IFN-gamma protect against liver injury during HAV infection in mice.
    J Virol. 2025;99:e0139525.
    >> Share

  24. XU L, Paine AC, Barbeau DJ, Klimstra W, et al
    Limiting viral replication in hematopoietic cells delays Rift Valley fever virus disease progression in C57BL/6 mice.
    J Virol. 2025;99:e0126125.
    >> Share

  25. YU X, Liu C-D, Shen S, Kim ES, et al
    Interferon alpha-inducible protein 27 (IFI27) inhibits hepatitis B virus (HBV) transcription through downregulating cellular transcription factor C/EBPalpha.
    J Virol. 2025 Oct 13:e0150925. doi: 10.1128/jvi.01509.
    >> Share

  26. MARCOE GJ, Larsen CIS, Summers MF, Majumder K, et al
    Association of hepatitis B virus genomes with active chromatin hubs challenges host replication fidelity, leading to DNA damage.
    J Virol. 2025 Oct 10:e0101425. doi: 10.1128/jvi.01014.
    >> Share

  27. SUN L, Snedeker A, Tang L
    A hepatitis B virus RNA-sensing and RNA-editing-dependent reporter system.
    J Virol. 2025 Oct 10:e0092225. doi: 10.1128/jvi.00922.
    >> Share

    September 2025
  28. MATSUI C, Yuliandari P, Deng L, Abe T, et al
    Hepatitis C virus NS3/4A protease cleaves SPG20, a key regulator of lipid droplet turnover, to promote lipid droplet formation.
    J Virol. 2025 Sep 23:e0089025. doi: 10.1128/jvi.00890.
    >> Share

  29. DING Y, Li Q, Sha Y, Si R, et al
    Multimodal characterization of the responsiveness of eight hepatitis D virus genotype isolates to interferon-alpha treatment.
    J Virol. 2025 Sep 18:e0128025. doi: 10.1128/jvi.01280.
    >> Share

  30. SAEED U, Kim J, Piracha ZZ, Kwon H, et al
    Retraction for Saeed et al., "Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner".
    J Virol. 2025 Sep 12:e0118725. doi: 10.1128/jvi.01187.
    >> Share

  31. PIRACHA ZZ, Kwon H, Saeed U, Kim J, et al
    Retraction for Piracha et al., "Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis through the AKT/GSK-3beta/beta-Catenin Signaling Pathway".
    J Virol. 2025 Sep 12:e0118625. doi: 10.1128/jvi.01186.
    >> Share

  32. HAGA Y, Babu E P, Swiderska-Syn M, Reagan EK, et al
    Hepatitis C virus modified (S)E2(F442NYT)-mRNA-LNP candidate vaccine promotes helper CXCR5(+)T cells.
    J Virol. 2025 Sep 5:e0135525. doi: 10.1128/jvi.01355.
    >> Share

  33. SCHWOERER MP, Carver S, Cafiero TR, Joyce B, et al
    Assessment of hepatitis C virus permissiveness in iteratively genetically humanized mice.
    J Virol. 2025 Sep 3:e0079325. doi: 10.1128/jvi.00793.
    >> Share

    August 2025
  34. SHI Z, Tsuge M, Collier N, Takeuchi Y, et al
    Modeling of hepatitis B virus infection spread in primary human hepatocytes.
    J Virol. 2025 Aug 4:e0092725. doi: 10.1128/jvi.00927.
    >> Share

    June 2025
  35. TRIPATHI SK, Li Y, Luo G
    Syndecan 2 proteoglycan serves as a hepatitis B virus cell attachment receptor.
    J Virol. 2025 Jun 26:e0079625. doi: 10.1128/jvi.00796.
    >> Share

  36. REXHOUSE C, Bailey JT, Moshkani S, Cimino JL, et al
    High antigen burden drives CD8+ T cell dysfunction in a mouse model of chronic hepatitis B virus infection.
    J Virol. 2025 Jun 12:e0071125. doi: 10.1128/jvi.00711.
    >> Share

  37. LI Y, Zheng X, Xie L, Kapustina M, et al
    Heat shock protein 90 chaperone activity is required for hepatitis A virus replication.
    J Virol. 2025 Jun 5:e0050225. doi: 10.1128/jvi.00502.
    >> Share

    April 2025
  38. WU S, Chen Z, Zhang Z, Xu J, et al
    Ubiquitin-dependent proteasomal degradation of small hepatitis B virus surface antigen mediated by TRIM21 and antagonized by OTUD4.
    J Virol. 2025 Apr 25:e0230924. doi: 10.1128/jvi.02309.
    >> Share

  39. YAN H, Peng B, He W, Zhong G, et al
    Correction for Yan et al., "Molecular Determinants of Hepatitis B and D Virus Entry Restriction in Mouse Sodium Taurocholate Cotransporting Polypeptide".
    J Virol. 2025 Apr 16:e0044525. doi: 10.1128/jvi.00445.
    >> Share

    March 2025
  40. CHEN F, Wettengel JM, Gegenfurtner F, Moosmuller J, et al
    Identification of NTCP animal orthologs supporting hepatitis B virus binding and infection.
    J Virol. 2025 Mar 5:e0183324. doi: 10.1128/jvi.01833.
    >> Share

    January 2025
  41. NOGALES A, Alonso C, Moreno S, Lorenzo G, et al
    Novel replication-competent reporter-expressing Rift Valley fever viruses for molecular studies.
    J Virol. 2025;99:e0178224.
    >> Share

  42. YAN H, Liu C, Li Y, Tang S, et al
    The characterization and structural basis of a human broadly binding antibody to HBV core protein.
    J Virol. 2025;99:e0169424.
    >> Share

  43. CHEN Z, Eggerman TL, Bocharov AV, Baranova IN, et al
    APOBEC-1 cofactors regulate APOBEC3-induced mutations in hepatitis B virus.
    J Virol. 2025 Jan 27:e0187924. doi: 10.1128/jvi.01879.
    >> Share

  44. HUANG H-E, Colasanti O, Li T-F, Lohmann V, et al
    Limited impact of hepatitis A virus 3C protease-mediated cleavage on the functions of NEMO in human hepatocytes.
    J Virol. 2025 Jan 24:e0226424. doi: 10.1128/jvi.02264.
    >> Share

  45. FEDORCHENKO SV, Klimenko Z, Martynovich T, Solianyk I, et al
    Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks.
    J Virol. 2025 Jan 22:e0184324. doi: 10.1128/jvi.01843.
    >> Share

    November 2024
  46. STEIGMANN JC, Zhou X, Suttenberg LN, Salman I, et al
    Effects of immunoproteasome inhibition on acute respiratory infection with murine hepatitis virus strain 1.
    J Virol. 2024 Nov 7:e0123824. doi: 10.1128/jvi.01238.
    >> Share

  47. KANG N, Liu N, Liu M, Zhang S, et al
    Identification and characterization of host factor VCPIP1 as a multi-functional positive regulator of hepatitis B virus.
    J Virol. 2024 Nov 4:e0158124. doi: 10.1128/jvi.01581.
    >> Share

    October 2024
  48. WU Y, Ren L, Mao C, Shen Z, et al
    Small hepatitis B virus surface antigen (SHBs) induces dyslipidemia by suppressing apolipoprotein-AII expression through ER stress-mediated modulation of HNF4alpha and C/EBPgamma.
    J Virol. 2024 Oct 29:e0123924. doi: 10.1128/jvi.01239.
    >> Share

  49. QUELLEC J, Piro-Megy C, Cannac M, Nisole S, et al
    Rift Valley fever virus is able to cross the human blood-brain barrier in vitro by direct infection with no deleterious effects.
    J Virol. 2024;98:e0126724.
    >> Share

  50. MATRENEC R, Oropeza CE, Dekoven E, Matrenec C, et al
    Foxa deficiency restricts hepatitis B virus biosynthesis through epigenic silencing.
    J Virol. 2024 Oct 8:e0137124. doi: 10.1128/jvi.01371.
    >> Share

  51. LI A, Zhao K, Duan Y, Zhang B, et al
    SARS-CoV-2 nsp13 suppresses hepatitis B virus replication by targeting cccDNA transcription.
    J Virol. 2024 Oct 7:e0104224. doi: 10.1128/jvi.01042.
    >> Share

    September 2024
  52. IBRAHIM MK, Liu C-D, Zhang L, Yu X, et al
    The loss of hepatitis B virus receptor NTCP/SLC10A1 in human liver cancer cells is due to epigenetic silencing.
    J Virol. 2024 Sep 19:e0118724. doi: 10.1128/jvi.01187.
    >> Share

    August 2024
  53. LOWERY SA, Schuster N, Wong L-YR, Carrillo T Jr, et al
    Mouse hepatitis virus JHMV I protein is required for maximal virulence.
    J Virol. 2024 Aug 19:e0068024. doi: 10.1128/jvi.00680.
    >> Share

    July 2024
  54. ZHANG J, Wang Q, Yuan W, Li J, et al
    Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions.
    J Virol. 2024 Jul 30:e0192923. doi: 10.1128/jvi.01929.
    >> Share

  55. MCMILLEN CM, Megli C, Radisic R, Skvarca LB, et al
    Vaccine strains of Rift Valley fever virus exhibit attenuation at the maternal-fetal placental interface.
    J Virol. 2024 Jul 17:e0098324. doi: 10.1128/jvi.00983.
    >> Share

    June 2024
  56. HE Q, Liu T, Yang X, Yuan D, et al
    Optimization of immunosuppression strategies for the establishment of chronic hepatitis E virus infection in rabbits.
    J Virol. 2024 Jun 20:e0084624. doi: 10.1128/jvi.00846.
    >> Share

  57. LIU J, Ito M, Liu L, Nakashima K, et al
    Involvement of ribosomal protein L17 and Y-box binding protein 1 in the assembly of hepatitis C virus potentially via their interaction with the 3' untranslated region of the viral genome.
    J Virol. 2024 Jun 20:e0052224. doi: 10.1128/jvi.00522.
    >> Share

  58. WOYTINEK K, Glitscher M, Hildt E
    Antagonism of epidermal growth factor receptor signaling favors hepatitis E virus life cycle.
    J Virol. 2024 Jun 10:e0058024. doi: 10.1128/jvi.00580.
    >> Share

    May 2024
  59. WON J, Kang HS, Kim NY, Dezhbord M, et al
    Tripartite motif-containing protein 21 is involved in IFN-gamma-induced suppression of hepatitis B virus by regulating hepatocyte nuclear factors.
    J Virol. 2024 May 23:e0046824. doi: 10.1128/jvi.00468.
    >> Share

  60. PARONETTO O, Allioux C, Dimeglio C, Lobjois L, et al
    Characterization of virus?host recombinant variants of the hepatitis E virus.
    J Virol. 2024 May 7:e0029524. doi: 10.1128/jvi.00295.
    >> Share

    April 2024
  61. SCHOLLMEIER A, Basic M, Glitscher M, Hildt E, et al
    The impact of HBx protein on mitochondrial dynamics and associated signaling pathways strongly depends on the hepatitis B virus genotype.
    J Virol. 2024 Apr 17:e0042424. doi: 10.1128/jvi.00424.
    >> Share

    March 2024
  62. SHENG Y, Deng Y, Li X, Ji P, et al
    Hepatitis E virus ORF3 protein hijacking thioredoxin domain-containing protein 5 (TXNDC5) for its stability to promote viral particle release.
    J Virol. 2024 Mar 29:e0164923. doi: 10.1128/jvi.01649.
    >> Share

  63. MCCOULLOUGH LC, Sadauskas T, Sozzi V, Mak KY, et al
    The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication.
    J Virol. 2024 Mar 19:e0153823. doi: 10.1128/jvi.01538.
    >> Share

  64. LI Y, Lemon SM
    Biochemical analysis of the host factor activity of ZCCHC14 in hepatitis A virus replication.
    J Virol. 2024 Mar 19:e0005724. doi: 10.1128/jvi.00057.
    >> Share

  65. TAMURA T, Yamamoto H, Ogino S, Morioka Y, et al
    A rapid and versatile reverse genetics approach for generating recombinant positive-strand RNA viruses that use IRES-mediated translation.
    J Virol. 2024;98:e0163823.
    >> Share

  66. BERKE JM, Tan Y, Sauviller S, Wu D-t, et al
    Class A capsid assembly modulator apoptotic elimination of hepatocytes with high HBV core antigen level in vivo is dependent on de novo core protein translation.
    J Virol. 2024;98:e0150223.
    >> Share

    February 2024
  67. FRERICKS N, Brown RJP, Reinecke BM, Herrmann M, et al
    Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes.
    J Virol. 2024 Feb 6:e0192123. doi: 10.1128/jvi.01921.
    >> Share

  68. NAKAJIMA S, Watashi K, Kato T, Muramatsu M, et al
    Correction for Nakajima et al., "Biochemical and Structural Properties of Entecavir-Resistant Hepatitis B Virus Polymerase with L180M/M204V Mutations".
    J Virol. 2024 Feb 2:e0182323. doi: 10.1128/jvi.01823.
    >> Share

    January 2024
  69. SHEN Z, Zhang S, Gao Z, Yu X, et al
    Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus.
    J Virol. 2024 Jan 16:e0134523. doi: 10.1128/jvi.01345.
    >> Share

  70. MATRENEC R, Oropeza CE, Dekoven E, Tarnow G, et al
    Ten-eleven translocation (Tet) methylcytosine dioxygenase-dependent viral DNA demethylation mediates in vivo hepatitis B virus (HBV) biosynthesis.
    J Virol. 2024 Jan 5:e0172123. doi: 10.1128/jvi.01721.
    >> Share

  71. CASIANO MATOS J, Harichandran K, Tang J, Sviridov DO, et al
    Hepatitis C virus E1 recruits high-density lipoprotein to support infectivity and evade antibody recognition.
    J Virol. 2024 Jan 4:e0084923. doi: 10.1128/jvi.00849.
    >> Share

    December 2023
  72. HAGA Y, Meyer K, Sung MMH, Reagan EK, et al
    Hepatitis C virus modified sE2(F442NYT) as an antigen in candidate vaccine facilitates human immune cell activation.
    J Virol. 2023 Dec 12:e0180923. doi: 10.1128/jvi.01809.
    >> Share

  73. GOBRAN ST, Pagliuzza A, Khedr O, Fert A, et al
    DAA-mediated HCV cure reduces HIV DNA levels in HCV/HIV coinfected people.
    J Virol. 2023 Dec 5:e0110523. doi: 10.1128/jvi.01105.
    >> Share

    November 2023
  74. BAJPAI PS, Collignon L, Solund C, Madsen LW, et al
    Full-length sequence analysis of hepatitis C virus genotype 3b strains and development of an in vivo infectious 3b cDNA clone.
    J Virol. 2023 Nov 21:e0092523. doi: 10.1128/jvi.00925.
    >> Share

  75. XU X, Zhang L, Ye G, Shi J, et al
    Hepatitis B doubly spliced protein (HBDSP) promotes hepatocellular carcinoma cell apoptosis via ETS1/GATA2/YY1-mediated p53 transcription.
    J Virol. 2023 Nov 6:e0108723. doi: 10.1128/jvi.01087.
    >> Share

    October 2023
  76. SEEGER C
    A CRISPR-based system to investigate HBV cccDNA biology.
    J Virol. 2023;97:e0118523.
    >> Share

  77. VANRUSSELT H, Kum DB, Taverniti V, Liu C, et al
    Novel non-HAP class A HBV capsid assembly modulators have distinct in vitro and in vivo profiles.
    J Virol. 2023;97:e0072223.
    >> Share

  78. ARIFFIANTO A, Deng L, Abe T, Matsui C, et al
    Oxidative stress sensor Keap1 recognizes HBx protein to activate the Nrf2/ARE signaling pathway, thereby inhibiting hepatitis B virus replication.
    J Virol. 2023 Oct 6:e0128723. doi: 10.1128/jvi.01287.
    >> Share

  79. LI Y, Yang Y, Li T, Wang Z, et al
    Activation of AIM2 by hepatitis B virus results in antiviral immunity that suppresses hepatitis C virus during coinfection.
    J Virol. 2023 Oct 3:e0109023. doi: 10.1128/jvi.01090.
    >> Share

    September 2023
  80. NEPAL S, Holmstrom ED
    Single-molecule-binding studies of antivirals targeting the hepatitis C virus core protein.
    J Virol. 2023 Sep 29:e0089223. doi: 10.1128/jvi.00892.
    >> Share

  81. XU L, Paine AC, Barbeau DJ, Alencastro F, et al
    Limiting viral replication in hepatocytes alters Rift Valley fever virus disease manifestations.
    J Virol. 2023;97:e0085323.
    >> Share

  82. SHEN S, Liu W, Zeng G, Liang H, et al
    Conditional replication and secretion of hepatitis B virus genome uncover the truncated 3' terminus of encapsidated viral pregenomic RNA.
    J Virol. 2023 Sep 27:e0076023. doi: 10.1128/jvi.00760.
    >> Share

  83. NAGASHIMA S, Primadharsini PP, Nishiyama T, Takahashi M, et al
    Development of a HiBiT-tagged reporter hepatitis E virus and its utility as an antiviral drug screening platform.
    J Virol. 2023 Sep 8:e0050823. doi: 10.1128/jvi.00508.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016